Location History:
- Newton, MA (US) (2001 - 2002)
- Rehovot, IL (2006 - 2011)
Company Filing History:
Years Active: 2001-2011
Title: Pennina Langer-Safer: Innovator in Molecular Sequence Analysis
Introduction
Pennina Langer-Safer is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of molecular biology, particularly in the analysis of nucleic acids. With a total of 5 patents to her name, her work has advanced the understanding of genetic sequences and their applications.
Latest Patents
One of her latest patents focuses on the identification of molecular sequence signatures and methods involving the same. This innovative approach provides novel means for analyzing hybridization data derived from hybridization assays between a target nucleic acid and differently sequenced polynucleotide probes. The methods involve selecting probe sets that define reference sequences for sequence signatures. They also derive useful data about the nature of the target nucleic acid molecule based on its hybridization to the probes. These methods are instrumental in determining whether the target contains a nucleic acid or polypeptide sequence signature, whether it encodes a member of a gene family, or whether it is derived from one of any number of genes.
Career Highlights
Pennina Langer-Safer is currently associated with Affymetrix, Inc., a company known for its advancements in genetic analysis technologies. Her work at Affymetrix has allowed her to push the boundaries of molecular biology and contribute to significant scientific advancements.
Collaborations
Throughout her career, Pennina has collaborated with notable colleagues, including David J Lockhart and Gordon G Wong. These collaborations have further enriched her research and innovation in the field.
Conclusion
Pennina Langer-Safer's contributions to molecular sequence analysis have established her as a leading inventor in her field. Her innovative patents and collaborations continue to influence the landscape of genetic research and technology.